Status:
UNKNOWN
Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques
Lead Sponsor:
University of Bari
Collaborating Sponsors:
Gaetano de Rienzo
Pasquale Ditonno
Conditions:
Benign Prostatic Hyperplasia (BPH)
Eligibility:
MALE
40-90 years
Phase:
NA
Brief Summary
in the last decade, lots of attemps have been done to identify new technologies able to reply the efficacy of gold standard technique for treating BPH, but with a better safety profile. The introducti...
Detailed Description
in the last decade, lots of attemps have been done to identify new technologies able to reply the efficacy of gold standard technique for treating BPH, but with a better safety profile. The introducti...
Eligibility Criteria
Inclusion
- moderate-to-severe lower urinary tract symptoms (IPSS ≥ 12)
- poor efficacy or tolerance to medical therapy for BPH
- transrectal ultrasound prostate volume between 30 and 120 ml
- ability to express written informed consent.
Exclusion
- previous surgical treatments for BPH
- indwelling bladder catheter or clean intermittent catheterization
- bladder stones
- severe detrusor hypocontractility (BCI \<50) or detrusorial acontractility
- urethral strictures
- neurological bladder
- not replaceable anticoagulant or antiplatelet drugs for severe cardiological comorbidity
- bladder cancer;
- diagnosis or clinical suspicion of prostatic cancer
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03846700
Start Date
March 1 2019
End Date
December 31 2019
Last Update
February 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bari "Aldo Moro"
Bari, Italy, 70124